SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Vericel Corp. (VCEL)

The PureGen osteoprogenitor cell allograft facilitates bone fusion,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
EZ2 Member Profile
 
Followed By 202
Posts 209,744
Boards Moderated 0
Alias Born 03/31/01
160x600 placeholder
Vericel to Present at 29th Annual Piper Jaffray Healthcare Conference "GlobeNewswire Inc." - 11/16/2017 4:10:00 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 11/14/2017 3:33:36 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/7/2017 9:14:03 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/7/2017 7:51:15 AM
Vericel Reports Third-Quarter 2017 Financial Results "GlobeNewswire Inc." - 11/7/2017 7:00:00 AM
Vericel to Host Third-Quarter 2017 Earnings Webcast and Conference Call on November 7, 2017 "GlobeNewswire Inc." - 10/25/2017 4:30:00 PM
Vericel Provides Business Updates at 2017 Cell & Gene Meeting on the Mesa "GlobeNewswire Inc." - 10/5/2017 7:00:00 AM
Vericel to Present at the 2017 Cell & Gene Meeting on the Mesa "GlobeNewswire Inc." - 9/27/2017 8:00:00 AM
Vericel to Present at the Ladenburg Thalmann 2017 Healthcare Conference "GlobeNewswire Inc." - 9/20/2017 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/19/2017 4:07:20 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 8/28/2017 12:36:33 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 8/14/2017 11:37:00 AM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 8/10/2017 4:22:07 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 8/10/2017 10:53:30 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/9/2017 2:09:27 PM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 8/9/2017 1:24:09 PM
Post-effective Amendment to an S-8 Filing (s-8 Pos) "Edgar (US Regulatory)" - 8/9/2017 8:43:06 AM
Post-effective Amendment to an S-8 Filing (s-8 Pos) "Edgar (US Regulatory)" - 8/9/2017 8:42:38 AM
Post-effective Amendment to an S-8 Filing (s-8 Pos) "Edgar (US Regulatory)" - 8/9/2017 8:42:38 AM
Post-effective Amendment to an S-8 Filing (s-8 Pos) "Edgar (US Regulatory)" - 8/9/2017 8:42:12 AM
Post-effective Amendment to an S-8 Filing (s-8 Pos) "Edgar (US Regulatory)" - 8/9/2017 8:41:43 AM
Post-effective Amendment to an S-8 Filing (s-8 Pos) "Edgar (US Regulatory)" - 8/9/2017 8:38:56 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/9/2017 8:22:56 AM
Vericel Reports Second-Quarter 2017 Financial Results "GlobeNewswire Inc." - 8/9/2017 7:00:00 AM
Vericel to Host Second-Quarter 2017 Earnings Webcast and Conference Call on August 9, 2017 "GlobeNewswire Inc." - 7/26/2017 8:00:00 AM
EZ2   Tuesday, 10/05/10 09:40:31 AM
Re: mkendra post# 2573
Post # of 7080 
Quote:
The PureGen osteoprogenitor cell allograft facilitates bone fusion, and is marketed exclusively by Alphatec Spine.

PureGen is an adult stem cell that provides cellular and growth factors needed for osteogenesis, without the potential complications of autograft.

Applied at the site of a musculoskeletal defect, PureGen mimics the regenerative environment of youthful tissues by increasing the concentration of stem cells available to repair tissue and build bone.



“There are those who don’t know and those who don’t know they don’t know.”

John Kenneth Galbraith
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist